IPL / Photofacial
Acne Treatment in Raleigh
Used to treat acne, this procedure involves applying a topical medication, 5-aminolevulinic acid (ALA), to the skin. The medication is left on the skin for a specified time. The area is then treated with blue light, IPL, or a pulsed dye laser.
When the ALA Solution is applied to the skin the solution is absorbed by the skin cells where it is converted to a chemical that makes the cells extremely sensitive to light. When the cells are exposed to the BLU-U, IPL or laser this energy activates the chemical and kills the P. acnes bacteria in your skin which causes acne.
The first step in the PDT System is the application of the ALA topical solution to the areas of concern on the individual as determined by the health care professional. This solution is an acid that occurs naturally in your body. It makes the P. acnes bacteria more sensitive to light. This application prepares the skin for step 2 in the PDT treatment. Once the ALA topical solution is applied to the skin, the doctor or health care professional will direct you to wait the recommended time in order to allow the solution to penetrate the target cells mentioned earlier.
After your incubation period, you will receive a blue light, IPL or laser treatment which is the second and the final step in the treatment. The light treatment time is determined by the health care professional.
Studies indicate that PDT provides treatment for both active lesions as well as other inactive sebaceous glands that are not creating active lesions.
Additional benefits of PDT may include:
Reduced pore size
More even skin tone
Reduced redness and flushing
Reduced wrinkle size
PhotoDynamic treatments are typically spaced at two to three week intervals. The number of your treatments, your treatment time and your treatment intervals may vary depending on the condition being treated.
The most common side effects include scaling/crusting, hypo/hyper-pigmentation, itching, stinging, and/or burning, erythema and edema. Severe stinging and/or burning at one or more lesions being treated was reported by at least 50% of patients at some time during the treatment.
Patients should avoid exposure of the photosensitive treatment sites to sunlight or bright indoor light prior to and at least 48 hours after blue light treatment. Exposure may result in a stinging and/or burning sensation and may cause erythema (redness) or edema (swelling) of the lesions. Sunscreens will not protect against photosensitivity reactions caused by visible light.